Inflammatory bowel disease revisited: newer drugs.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Scandinavian Journal of Gastroenterology, Supplement

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/00365529009093133PMID 1978406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.

  2009cited by this paper
• Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis.

  1990cited by this paper
• Selective 5-lipoxygenase inhibition in ulcerative colitis.

  1990cited by this paper
• T-lymphocyte-antigen interactions in transplant rejection.

  1990cited by this paper
• Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview.

  1990cited by this paper
• Liver Disorders in Children, Alex P. Mowat (Ed.). Butterworth, Stoneham, Massachusetts (1987), 408 pp., $75.00 ISBN: 0-407-00480-7

  1989cited by this paper
• Interleukin-1 and its biologically related cytokines.

  1989cited by this paper
• Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.

  1989cited by this paper
• Does smoking tighten the gut?

  1989cited by this paper
• A meta-analysis of the role of smoking in inflammatory bowel disease

  1989cited by this paper
• Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease.

  1989cited by this paper
• Treatment of diversion colitis with short-chain-fatty acid irrigation.

  1989cited by this paper
• 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.

  1989cited by this paper
• Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

  1989cited by this paper
• Interleukins and the immune system 2.

  1989cited by this paper
• Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes.

  1989cited by this paper
• Immune recognition of antigen and its relevance to autoimmune disease: recent advances at the molecular level

  1989cited by this paper
• Assessment of salicylate derivatives for potential use in ulcerative colitis: proposal for a new action of 5-aminosalicylic acid?

  1989cited by this paper
• 5-ASA enema therapy.

  1989cited by this paper
• 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity.

  1989cited by this paper
• FK 506 for liver, kidney, and pancreas transplantation.

  1989cited by this paper
• Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease.

  1989cited by this paper
• Antibiotics and inflammatory bowel diseases.

  1989cited by this paper
• Oxygen radicals: mediators of gastrointestinal pathophysiology.

  1989cited by this paper
• Interleukins and the immune system 1.

  1989cited by this paper
• 肝,腎,およびすい臓移植のためのFK506

  1989cited by this paper
• Inhibition of antibody secretion by 5-aminosalicylic acid.

  1989cited by this paper
• The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

  1989cited by this paper
• Topical corticosteroids in inflammatory bowel disease.

  1989cited by this paper
• A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

  1989cited by this paper
• Therapeutic potential of fish oil in the treatment of ulcerative colitis

  1989cited by this paper
• Clinical Experience with Tixocortol Pivalate

  1988cited by this paper
• Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.

  1988cited by this paper
• Role of neuropeptides, nerves and mast cells in intestinal immunity and physiology.

  1988cited by this paper
• Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease.

  1988cited by this paper
• Sulfasalazine: II. Some notes on the discovery and development of salazopyrin.

  1988cited by this paper
• Cyclosporine: Is There a Role in Inflammatory Bowel Disease?

  1988cited by this paper
• Free Radicals in Gastroenterology: A Review

  1988cited by this paper
• Primary biliary cirrhosis treated with low-dose oral pulse methotrexate.

  1988cited by this paper
• Alterations of the immune system in ulcerative colitis and Crohn's disease.

  1988cited by this paper
• Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms.

  1988cited by this paper
• Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum.

  1987cited by this paper
• Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease.

  1987cited by this paper
• In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.

  1987cited by this paper
• Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

  1987cited by this paper
• Azathioprine-induced in vitro inhibition of prostaglandin E2 production by rabbit retina.

  1987cited by this paper
• Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

  1987cited by this paper
• Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.

  1987cited by this paper
• Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.

  1987cited by this paper
• Effects of Omega-3 Polyunsaturated Fatty Acids on Human Leukocyte Function and Biochemistry

  1987cited by this paper
• Glycoproteins in inflammatory bowel disease

  1987cited by this paper
• Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor.

  1986cited by this paper
• Scientific basis for the clinical use of superoxide dismutase.

  1986cited by this paper
• Use of alpha-tocopherylquinone in the treatment of ulcerative colitis.

  1986cited by this paper
• Smoking and colonic mucus in ulcerative colitis.

  1986cited by this paper
• Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.

  1986cited by this paper
• Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid

  1985cited by this paper
• Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway.

  1985cited by this paper
• Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?

  1985cited by this paper
• Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.

  1985cited by this paper
• Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.

  1985cited by this paper
• Treatment of Ulcerative Colitis With Clonidine

  1985cited by this paper
• Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis.

  1984cited by this paper
• Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

  1984cited by this paper
• Cyclosporin for Crohn's disease.

  1984cited by this paper
• European cooperative Crohn's disease study (ECCDS) : Results of drug treatment

  1984cited by this paper
• European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.

  1984cited by this paper
• Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.

  1984cited by this paper
• Absorption of 151chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease

  1983cited by this paper
• Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease.

  1983cited by this paper
• A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.

  1982cited by this paper
• Recent Developments in Nonspecific Inflammatory Bowel Disease

  1982cited by this paper
• Corticosteroid‐Mediated Immunoregulation in Man

  1982cited by this paper
• Metronidazole therapy for perineal Crohn's disease: a follow-up study.

  1982cited by this paper
• Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.

  1981cited by this paper
• Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.

  1980cited by this paper
• The colonic epithelium in ulcerative colitis: an energy-deficiency disease?

  1980cited by this paper
• National Cooperative Crohn's Disease Study: results of drug treatment.

  1979cited by this paper
• An experiment to determine the active therapeutic moiety of sulphasalazine.

  1977cited by this paper
• Suppression of cell-mediated immunity by metronidazole.

  1977cited by this paper
• Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis.

  1976cited by this paper
• ABSORPTION OF PENTAGASTRIN FROM GASTROINTESTINAL TRACT IN MAN

  1975cited by this paper
• Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

  1973cited by this paper
• Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.

  1967cited by this paper
• Factors affecting the response of immunized guinea pigs to antigenic stimulus; further observations.

  1949cited by this paper

• Reduction of rectal toxicity in prostate cancer radiation therapy by implantable rectum spacers

  2018cites this paper
• Chronic radiation proctitis: tricks to prevent and treat

  2015cites this paper
• Nonendoscopic therapies for the management of radiation-induced rectal bleeding

  2013cites this paper
• Spectrophotometric Methods for Quantitative Determination of Mesalamine in Bulk and Tablet Dosage Forms

  2010cites this paper
• Ist die Colitis ulcerosa eine Autoimmunerkrankung?

  2009cites this paper
• Validation of HPLC, DPPH and nitrosation methods for mesalamine determination in pharmaceutical dosage forms

  2007cites this paper
• Therapeutic opportunities in colon-specific drug-delivery systems.

  2007cites this paper
• Drug utilization study in patients with Crohn's disease in Spain

  2003cites this paper
• Metronidazole in the treatment of chronic radiation proctitis: clinical trial.

  2000cites this paper
• Colonic lymphocyte and plasma cell populations in dogs with lymphocytic-plasmacytic colitis.

  1999cites this paper
• Inflammatory bowel disease. Current perspectives.

  1999cites this paper
• Inflammatory bowel disease. Current perspectives.

  1999cites this paper
• A Comparative Review of Topical Therapies for Inflammatory Bowel Disease

  1996cites this paper
• New therapeutic approaches.

  1995cites this paper
• To Use or Not to Use Cyclosporine-A: That is the Question.

  1995cites this paper
• Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.

  1995cites this paper
• Approaches and opportunities in colon-specific drug delivery.

  1995cites this paper
• Plasma somatostatin levels in ulcerative colitis.

  1994cites this paper
• Crohn's disease.

  1993cites this paper
• Medical therapy of ulcerative colitis.

  1993cites this paper
• New therapeutic agents in the treatment of inflammatory bowel disease.

  1992cites this paper
• [Is ulcerative colitis an autoimmune disease?].

  1992cites this paper
• New developments in the pharmacotherapy of inflammatory bowel disease

  1992cites this paper
• Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel Disease

  1991cites this paper
• Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.

  1991cites this paper